Emrelis is the first FDA-approved treatment for previously treated patients with locally advanced or metastatic non-squamous ...

We finally have a schedule for the New England Patriots 2025 season. Dan Roche discusses his thoughts on the upcoming season with Joe Weil.

The antibody-drug conjugate is approved for previously treated advanced NSCLC patients with high c-Met protein overexpression ...

I knew it was bound to happen at some point, but this soon – if you’re thinking in context, 10 years is not that far off. So, ...

Roche warned that President Trump's executive order on drug pricing threatens its planned $50 billion investment in the ...

Roche is among several drugmakers to announce large-scale U.S. investments in response to Trump's push to onshore ...

The test detects the MET protein that is over-expressed in some patients with non-squamous non-small cell lung cancer.

While M&A activity slowed in the first quarter of 2025, including in life sciences, there have been plenty of noteworthy developments in the ...

U.S. President Donald Trump's executive order on drug pricing threatens Roche's planned $50 billion investment in the United ...

A new promo for Roche’s blockbuster hemophilia A drug Hemlibra focuses less on those with the genetic bleeding disorder and ...

President Donald Trump's executive order on drug pricing may threaten Roche's planned $50 billion investment in the U.S. By ...

Roche will invest up to $550 million in its Indianapolis diagnostics site by 2030 to expand production of its continuous glucose monitoring systems. The Indianapolis location serves as the ...